Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Helen Susan Kim files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- EcoR1 Capital, LLC - $40.00M in AKTS purchases and sales in the last 12 months
- Ansbert Gadicke - $20.03M in AKTS purchases and sales in the last 12 months
- MPM BIOVENTURES 2018, L.P. - $20.03M in AKTS purchases and sales in the last 12 months
- Vida Ventures II, LLC - $15.03M in AKTS purchases and sales in the last 12 months
- Todd Foley - $4.19M in AKTS purchases and sales in the last 12 months
- Akos Czibere - $1.65M in AKTS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Helen Susan Kim?
Helen Susan Kim is a corporate insider of Aktis Oncology, Inc. (AKTS). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Helen Susan Kim last file a Form 4?
The only primary Form 4 on record is dated 12 January 2026.
Has Helen Susan Kim been buying or selling stock?
Recorded transactions: 2 open-market purchases ($15.03M) and 0 open-market sales across all tracked filings.
